Provided are a mutant of an H3N2 subtype influenza virus hemagglutinin protein, a preparation method therefor, and a method of using the mutant to prevent and/or treat infections of an influenza virus and/or diseases (such as influenza) caused by the infections. Further provided is a pharmaceutical composition containing the mutant, such as a vaccine.